Smith & Nephew (NYSE:SNN) said today that it’s adding a total knee arthroplasty application to the Navio handheld robot-assisted platform. The European Union’s largest orthopedics player said the Navio system can be used with its Journey II, Legion Primary and Genesis II total knees. Smith & Nephew acquired Minnesota-based Blue Belt Technologies – Navio’s original maker – […]
Blue Belt Technologies
A New York hospital is the 1st to use Smith & Nephew (NYSE:SNN) new robotics-assisted total knee replacement procedure following its recent 510(k) clearance from the FDA. The surgery took place at the John T. Mather Memorial Hospital in Port Jefferson, N.Y., involving Smith & Nephew’s handheld robotics-assisted Navio platform, and its Journey II BCS knee […]
Smith & Nephew (NYSE:SNN) said today that it closed its $275 million acquisition of robot-assisted surgery company Blue Belt Technologies. Minneapolis-based Blue Belt makes the portable Navio system, which is designed to work with 8 different knee systems, including Smith & Nephew’s Zuk and Journey Uni devices. The London-based medical products giant, noting that Blue Belt is its “most successful” […]
Smith & Nephew (NYSE:SNN) said today that it agreed to acquire robot-assisted surgery company Blue Belt Technologies for $275 million, but missed top-line expectations for the 3rd quarter. Minneapolis-based Blue Belt makes the portable Navio system, which is designed to work with 8 different knee systems, including Smith & Nephew’s Zuk and Journey Uni devices. The London-based medical products giant, […]
Blue Belt Technologies said yesterday its Navio robotic-assisted surgical system was used in its 1st partial knee replacement, using Smith & Nephew‘s (FTSE:SN, NYSE:SNN) ZUK unicompartmental knee. The Navio is a robotic-assisted, CT-free navigation handheld robotics system and bone-cutting tool that aids operating surgeons in bone-shaping tasks through minimally invasive incisions, according to the company. “The ZUK […]
Medical device giant Covidien is doubling down on emerging markets, expanding an investment program that the company had, at one point, thought would be over by the end of 2013.
Blue Belt Technologies announced another major regulatory win with FDA clearance for its Stride unicondylar knee device, designed to be paired with the company’s U.S.-approved NavioPFS orthopedic implantation system.